Tony Hunter, Brian Druker and John Mendelsohn have won this year’s Tang Prize in biopharmaceutical science for their breakthroughs in developing targeted cancer therapies, the Tang Prize Selection Committee announced yesterday.
Their research and findings of protein tyrosine phosphorylation and tyrosine kinases as oncogenes have led to successful targeted cancer therapies, the committee said.
The three winners, all Americans, have shown how basic science can lead to clinical applications that benefit humankind, said Chang Wen-chang (張文昌), a member of Academia Sinica and the convener of the selection committee.
Photo: CNA
Hunter demonstrated that a mechanism called tyrosine phosphorylation acts as a master on/off switch for a number of key proteins that are critical for successful cancer therapies, the committee said.
Hunter, a professor of biology at the Salk Institute, gave birth to the field of targeted therapies after discovering in 1979 the mechanism of tyrosine phosphorylation and that the oncogene Src is a tyrosine kinase.
The historic discovery paved the way for active research in the following two decades on tyrosine kinase oncogenes, ultimately leading to the development of tyrosine kinase inhibitors (TKIs).
Based on Hunter’s discovery, Druker, the director of Oregon Health & Science University’s Knight Cancer Institute, led the successful clinical trial of a cancer-fighting drug called imatinib.
The drug turned chronic myelogenous leukemia, a cancer that once had a very low survival rate, into a manageable condition.
Gleevec, a brand of imatinib, shuts off oncogenic signals by inhibiting Abl-protein tyrosine kinases as predicted by Hunter’s original research, the committee said.
Gleevec has also been successfully used in the treatment of acute lymphocytic leukemia and certain types of gastrointestinal stromal tumors by inhibiting other tyrosine kinase oncoproteins.
There are more than 26 TKIs that have been approved for clinical use. All of the discoveries have Druker’s first successful trials to thank because they spurred this still burgeoning targeted therapy era, the committee said.
John Mendelsohn, president emeritus of MD Anderson Cancer Center, took another approach to combating cancer.
An alternative way of shutting off the activities of tyrosine kinases on the cell surface (receptor tyrosine kinase) is to develop antibodies against the extracellular domain of the receptor, the committee said.
In such a way, the natural ligand, or growth factor, can no longer bind and the receptor tyrosine kinase is no longer activated. Mendelsohn and his team came up with the idea that antibodies targeting the epidermal growth factor receptor (EGFR) may be an effective strategy for cancer treatment.
Mendelsohn led his team in conducting preclinical research and proceeded to develop the anti-EGFR antibody cetuximab, which eventually won the US Food and Drug Administration’s approval for the treatment of colon cancer and head/neck cancer.
SHIPS, TRAINS AND AUTOMOBILES: The ministry has announced changes to varied transportation industries taking effect soon, with a number of effects for passengers Beginning next month, the post office is canceling signature upon delivery and written inquiry services for international registered small packets in accordance with the new policy of the Universal Postal Union, the Ministry of Transportation and Communications said yesterday. The new policy does not apply to packets that are to be delivered to China, the ministry said. Senders of international registered small packets would receive a NT$10 rebate on postage if the packets are sent from Jan. 1 to March 31, it added. The ministry said that three other policies are also scheduled to take effect next month. International cruise ship operators
HORROR STORIES: One victim recounted not realizing they had been stabbed and seeing people bleeding, while another recalled breaking down in tears after fleeing A man on Friday died after he tried to fight the knife-wielding suspect who went on a stabbing spree near two of Taipei’s busiest metro stations, Taipei Mayor Chiang Wan-an (蔣萬安) said. The 57-year-old man, identified by his family name, Yu (余), encountered the suspect at Exit M7 of Taipei Main Station and immediately tried to stop him, but was fatally wounded and later died, Chiang said, calling the incident “heartbreaking.” Yu’s family would receive at least NT$5 million (US$158,584) in compensation through the Taipei Rapid Transit Corp’s (TRTC) insurance coverage, he said after convening an emergency security response meeting yesterday morning. National
PLANNED: The suspect visited the crime scene before the killings, seeking information on how to access the roof, and had extensively researched a 2014 stabbing incident The suspect in a stabbing attack that killed three people and injured 11 in Taipei on Friday had planned the assault and set fires at other locations earlier in the day, law enforcement officials said yesterday. National Police Agency (NPA) Director-General Chang Jung-hsin (張榮興) said the suspect, a 27-year-old man named Chang Wen (張文), began the attacks at 3:40pm, first setting off smoke bombs on a road, damaging cars and motorbikes. Earlier, Chang Wen set fire to a rental room where he was staying on Gongyuan Road in Zhongzheng District (中正), Chang Jung-hsin said. The suspect later threw smoke grenades near two exits
The Forestry and Nature Conservation Agency yesterday launched a gift box to market honey “certified by a Formosan black bear” in appreciation of a beekeeper’s amicable interaction with a honey-thieving bear. Beekeeper Chih Ming-chen (池明鎮) in January inspected his bee farm in Hualien County’s Jhuosi Township (卓溪) and found that more than 20 beehives had been destroyed and many hives were eaten, with bear droppings and paw prints near the destroyed hives, the agency said. Chih returned to the farm to move the remaining beehives away that evening when he encountered a Formosan black bear only 20m away, the agency said. The bear
RSS